397030 — AprilBio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for AprilBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,132	54,377	68,784	63,587	94,482
Net Total Accounts Receivable
Net Total Receivables	30.6	4,459	436	925	1,816
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18,005	59,395	69,359	66,728	96,626
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,244	1,667	1,337	1,337	1,200
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	19,410	61,376	71,065	79,702	99,599
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33,052	4,045	1,787	21,746	8,482
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	33,187	4,211	1,903	21,954	8,611
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	-13,777	57,165	69,162	57,747	90,988
Total Liabilities & Shareholders' Equity	19,410	61,376	71,065	79,702	99,599
Total Common Shares Outstanding